Screener
Amneal Pharmaceuticals, Inc. AMRX Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s restricted cash?
- Amneal Pharmaceuticals, Inc. (AMRX) reported restricted cash of $8.64M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s restricted cash changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s restricted cash decreased by 10.4% year-over-year, from $9.64M to $8.64M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s restricted cash has grown at a 38.1% compound annual growth rate (CAGR), from $5.74M to $28.84M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Amneal Pharmaceuticals, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude